Novartis acquires Avidity Biosciences for $12B to boost growth and rare disease pipeline. Explore impacts, risks, and outlook ...

Americans’ pockets hold digital devices delivering oceans of information and distractions. But another technology that ...

In October 2025, Genentech, in collaboration with Natera, announced positive phase 3 IMvigor011 trial results showing that the Signatera test improved disease-free and overall survival in ...

The "Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2025" report highlights significant R&D opportunities with over 20 companies and 22 pipeline drugs, focusing on innovative treatments like ...

Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

An African state-owned diamond company has submitted a formal offer to buy South African diamond mining giant De Beers.

Christopher Ruane explains how a fiver a day could be enough for someone to start investing now and build a six figure ...

Pacira intends to vigorously assert and enforce its intellectual property rights and has 45 days from receipt of the PIV Notice to file a lawsuit if it deems the ANDA filer is infringing its ...

The global obesity market is projected to exceed $100 billion annually by the end of the decade, driven by unprecedented demand for GLP-1 therapies. BioRestorative’s ThermoStem ® platform is uniquely ...

Prassanna Rao Rajgopal integrates cybersecurity as an engine of trust and business growth, rather than a brake, by ...

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.

Novartis AG ( NYSE: NVS) M&A Call October 27, 2025 8:00 AM EDT ...